Stocks Higher as In...
Health Care: Drugs
Teva Pharmaceutical Industries Ltd (TEVA: NYSE)
$39.64 0.32 | 0.81%
06/18/13 - 04:03 PM ET
Latest Dividend:0.27
Latest Dividend Yield:2.42%
Dividend Ex-Date:05/16/13
Price Earnings Ratio:17.37
Price Earnings Comparisons:
| TEVA | Sector Avg. | S&P 500 |
|---|---|---|
| 17.37 | 19.40 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -3.67 | 3.83 | -27.48 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 10.90 | 0.46 | 0.13 |
| Net Income | -30.80 | -0.05 | -0.02 |
| EPS | -27.20 | -0.02 | -0.01 |
Earnings for TEVA:
| EBITDA | 5.89B |
| REVENUE | 20.32B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.20 | $1.30 | $5.04 | $5.46 |
| Number of Analysts | 15 | 15 | 16 | 15 |
| High Estimate | $1.32 | $1.33 | $5.17 | $5.94 |
| Low Estimate | $1.04 | $1.27 | $4.86 | $4.86 |
| Prior Year | $1.28 | $1.28 | $5.35 | $5.04 |
| Growth Rate (Year over Year) | -6.15% | 1.41% | -5.71% | 8.32% |
Portfolios with TEVA
- Portfolio NameUser Type
- UserDonnie Portfolio 2 High Grade
- UserMain
- UserLong Term Stock Picks
- UserTRIG
- Userfun and games
- Userabangser Portfolio 1
- ContributorHighest-Yielding Drug Stocks
- Contributor8 Pharma Stocks to Watch
- Userdividend
- UserIncome stocks
Latest TEVA Headlines from TheStreet
- Cooper Tire Sells to Apollo Tyres
06.12.13 | 11:06 am - Cooper Tire Is Bought for $2.22 Billion: Ahead of the Ticker 06.12.13 | 10:06 am
- Teva Pharmaceutical Industries Ltd Stock Upgraded (TEVA) 06.11.13 | 10:06 am
- Teva Pharmaceutical Industries Ltd Stock Buy Recommendation Reiterated (TEVA) 06.11.13 | 10:06 am
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner 06.10.13 | 05:06 pm
- 5 Drugs Stocks On The Rise 06.10.13 | 01:06 pm
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 06.03.13 | 10:06 am
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 05.21.13 | 10:05 am
- Ireland Welcomes Watson Pharmaceuticals, an American Success 05.20.13 | 02:05 pm
- 4 Stocks Improving Performance Of The Health Care Sector 05.16.13 | 01:05 pm
Press Releases for TEVA
- Apolo Anton Ohno And Teva Respiratory Announce Finalists In National EIB All Starsâ¿¢ Contest - PR Newswire 04.16.13 | 08:04 am
- OncoGenex Announces Plans For The Initiation Of The Spruceâ¿¢ Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Non-Squamous Non-Small Cell Lung Cancer - PR Newswire 04.11.13 | 08:04 am
- Early Versus Delayed Treatment With Laquinimod Demonstrated Significant Reduction In Risk Of Disability Progression – Results Of Three-Year ALLEGRO Study In Relapsing-Remitting Multiple Sclerosis - Business Wire 03.21.13 | 08:03 am
- New Data Show Azilect® (rasagiline Tablets) Provided Clinical Benefit In Patients With Early Parkinson’s When Added To Sub-Optimally Controlled Patients On Dopamine Agonist Therapy - Business Wire 03.20.13 | 07:03 am
- Teva To Present New Research On CNS Product Portfolio And Pipeline At 2013 American Academy Of Neurology Annual Meeting - Business Wire 03.14.13 | 09:03 am
- Clay Walker, Country Music Star And Relapsing-Remitting Multiple Sclerosis Patient Urges Others To "Stick With It" - PR Newswire 03.13.13 | 08:03 am
- Teva Files 2012 Annual Report On Form 20-F - Business Wire 03.08.13 | 04:03 pm
- First Patient Enrolled In Third Phase III Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis - Business Wire 03.06.13 | 08:03 am
- Phase III Study Of Teva’s Milprosa™ (Progesterone) Vaginal Ring Published In Fertility And Sterility - Business Wire 03.04.13 | 08:03 am
- Teva Calls 5.550% Senior Notes Due 2016 For Redemption - Business Wire 03.01.13 | 09:03 am
Partner Headlines for TEVA
- $2.15B Settlement for Pfizer's Protonix - Analyst Blog - Zacks 06.13.13 | 11:06 pm
- SGEN Starts Adcetris Phase I/II Study - Analyst Blog - Zacks 06.12.13 | 12:06 am
- FDA Accepts Teva sNDA - Analyst Blog - Zacks 06.01.13 | 12:06 am
- Obamacare Will Make this Pharmaceutical Company Skyrocket - NASDAQ 05.29.13 | 01:05 pm
- Teva Pharmaceutical Industries Limited Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet 05.02.13 | 10:05 am
- Teva Pharmaceutical Industries Limited Earnings: Here’s Why the Stock is Up Now - Wall St. Cheat Sheet 05.02.13 | 09:05 am
- Analysts: SanDisk Will Beat Estimates and 4 New Opinions Investors Must Take Note Of - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- FDA Approves NDA for Teva's Quartette Tablets to Prevent Pregnancy - Benzinga 03.29.13 | 11:03 am
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
